InvestorsHub Logo
Followers 139
Posts 23253
Boards Moderated 0
Alias Born 04/08/2004

Re: BIOChecker4 post# 397952

Friday, 01/13/2023 11:24:27 AM

Friday, January 13, 2023 11:24:27 AM

Post# of 463647
We heard GREAT NEWS yesterday!!! THAT is a FACT!!!

https://jpmorgan.metameetings.net/events/healthcare23/general_signin?gpu_only=true

ANAVEX®2-73 (BLARCAMESINE) PHASE 2B/3 STUDY MET PRIMARY AND KEY SECONDARY ENDPOINTS,
SHOWING STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN GLOBAL CLINICAL STUDY OF PATIENTS WITH EARLY ALZHEIMER’S DISEASE

Robust, Statistically Significant and Clinically Meaningful Absolute Improvement in Cognitive Function as Measured by ADAS-Cog and ADCS-ADL
Key Secondary Endpoint CDR-SB Also Met, Demonstrating Statistically Significant Results

AND NOT JUST THAT

The Phase 2b/3 results were BETTER THAN EXPECTED.

Good luck and GOD bless,
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News